Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01605019 · ClinicalTrials.gov registry record · NA
The Use of CoSeal (Sealant Agent) in Patients During Left Ventricular Assist Device Surgery
A NA study, sponsored by The Methodist Hospital Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01605019 is a NA study that was terminated before completion, run by The Methodist Hospital Research Institute. The registered enrollment target is 4 participants.
The verdict
NCT01605019, a NA study, was terminated before completion, sponsored by The Methodist Hospital Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of a device called CoSeal™. CoSeal™ is an FDA approved synthetic (man-made) surgical sealant which is currently used to help stop leaks in blood vessels during surgery. This study is evaluating CoSeal™ when it is applied to various areas of the heart during the surgery to implant a Left Ventricular Assist Device (LVAD). the investigators are looking for evidence which indicates that CoSeal™ may be useful in reducing or stopping bleeding, the occurrence of micro emboli (small particles of air or blood), and the formation of cardiac adhesions (scar tissue strands that may form around the heart in the area of a previous LVAD operation) in patients who undergo LVAD implantation surgery.
Interventions
- DEVICE CoSeal
- DEVICE BioGlue® Surgical Adhesive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01605019
The ClinicalTrials.gov registry entry for NCT01605019 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CoSeal is the first listed.
NCT01605019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01605019 about?
NCT01605019 is a clinical study titled "The Use of CoSeal (Sealant Agent) in Patients During Left Ventricular Assist Device Surgery". The purpose of this study is to evaluate the use of a device called CoSeal™. CoSeal™ is an FDA approved synthetic (man-made) surgical sealant which is currently used to help stop leaks in blood vessels during surgery. This study is evaluating CoSeal™ when it is applied to various areas of the heart...
What is the current status of trial NCT01605019?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2012-06. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01605019?
The interventions under investigation include: CoSeal (DEVICE), BioGlue® Surgical Adhesive (DEVICE).
Who is sponsoring clinical trial NCT01605019?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.